Estabrook Capital Management’s Smith & Wesson SWBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,350
Closed -$17.5K 356
2024
Q3
$17.5K Hold
1,350
﹤0.01% 247
2024
Q2
$19.4K Hold
1,350
﹤0.01% 244
2024
Q1
$23.4K Hold
1,350
﹤0.01% 242
2023
Q4
$18.3K Hold
1,350
﹤0.01% 256
2023
Q3
$17.4K Hold
1,350
﹤0.01% 260
2023
Q2
$17.6K Hold
1,350
﹤0.01% 267
2023
Q1
$16.6K Hold
1,350
﹤0.01% 280
2022
Q4
$11.7K Hold
1,350
﹤0.01% 295
2022
Q3
$14K Hold
1,350
﹤0.01% 285
2022
Q2
$17.7K Hold
1,350
﹤0.01% 288
2022
Q1
$20.4K Hold
1,350
﹤0.01% 278
2021
Q4
$24K Buy
+1,350
New +$27.9K ﹤0.01% 276

Other funds holding SWBI

Estabrook Capital Management's SWBI Position: Q4 2024 in Review

Estabrook Capital Management sold out of Smith & Wesson (SWBI) in Q4 2024, closing a stake of 1,350 shares — an estimated $17.5K sold.

Estabrook Capital Management first reported a position in SWBI in Q4 2021 and held it in 12 quarters. The position peaked at $24K in Q4 2021. 182 funds tracked by Wall St. Rank hold SWBI as of Q4 2024.

  • Estabrook Capital Management reported no remaining Smith & Wesson position as of Q4 2024 after selling out during the quarter.
  • Estabrook Capital Management sold 1,350 Smith & Wesson shares in Q4 2024, an estimated $17.5K.
  • Estabrook Capital Management first reported a position in Smith & Wesson in Q4 2021 and held it in 12 quarters.
  • Estabrook Capital Management's Smith & Wesson position peaked at $24K in Q4 2021.
  • 182 funds tracked by Wall St. Rank held Smith & Wesson as of Q4 2024.

Based on Estabrook Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.